Further, an exploration of the relationship between NAT10 protein level and the clinicopathological characteristics of patients with CRC showed that tumor stage, lymph node metastasis, vascular invasion, and distant metastasis were statistically significantly associated with NAT10 expression (Table 1). The gene discussed is NAT10; the disease is neoplasm.